Gui Ying Wu

2.3k total citations
34 papers, 1.8k citations indexed

About

Gui Ying Wu is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gui Ying Wu has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biological Psychiatry, 13 papers in Psychiatry and Mental health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gui Ying Wu's work include Tryptophan and brain disorders (15 papers), Schizophrenia research and treatment (13 papers) and Stress Responses and Cortisol (9 papers). Gui Ying Wu is often cited by papers focused on Tryptophan and brain disorders (15 papers), Schizophrenia research and treatment (13 papers) and Stress Responses and Cortisol (9 papers). Gui Ying Wu collaborates with scholars based in China, United States and Canada. Gui Ying Wu's co-authors include Lian Yuan Cao, Dong Zhou, Xiang Yang Zhang, Xiangyang Zhang, Yu Shen, Pei Yan Zhang, Therese A. Kosten, Thomas R. Kosten, Yun Tan and Dong Zhou and has published in prestigious journals such as Brain Research, Neuroscience and Neuropsychopharmacology.

In The Last Decade

Gui Ying Wu

34 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gui Ying Wu China	25	972	617	509	327	325	34	1.8k
Lian Yuan Cao China	19	915 0.9×	522 0.8×	482 0.9×	336 1.0×	231 0.7×	22	1.6k
Ana Pocivavsek United States	25	1.0k 1.0×	384 0.6×	618 1.2×	229 0.7×	457 1.4×	48	1.8k
Lilly Schwieler Sweden	28	1.6k 1.7×	739 1.2×	890 1.7×	328 1.0×	474 1.5×	64	2.2k
Sinead M. Gibney Ireland	15	896 0.9×	242 0.4×	577 1.1×	270 0.8×	265 0.8×	22	1.6k
Gabriela Delevati Colpo United States	27	783 0.8×	851 1.4×	242 0.5×	415 1.3×	531 1.6×	66	2.4k
Harry Steinbusch Netherlands	19	644 0.7×	229 0.4×	561 1.1×	448 1.4×	421 1.3×	31	1.9k
Ewa M. Urbańska Poland	24	937 1.0×	513 0.8×	547 1.1×	410 1.3×	385 1.2×	85	1.6k
Erik Pålsson Sweden	27	574 0.6×	914 1.5×	178 0.3×	369 1.1×	371 1.1×	85	2.0k
Ewa Obuchowicz Poland	21	690 0.7×	206 0.3×	615 1.2×	461 1.4×	382 1.2×	79	1.7k
Ralf Brisch Germany	20	1.3k 1.4×	496 0.8×	783 1.5×	559 1.7×	643 2.0×	41	2.6k

Countries citing papers authored by Gui Ying Wu

Since Specialization

Citations

This map shows the geographic impact of Gui Ying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui Ying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui Ying Wu more than expected).

Fields of papers citing papers by Gui Ying Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui Ying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui Ying Wu. The network helps show where Gui Ying Wu may publish in the future.

Co-authorship network of co-authors of Gui Ying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Gui Ying Wu. A scholar is included among the top collaborators of Gui Ying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui Ying Wu. Gui Ying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiang Yang, Mei Hong Xiu, Cai Song, et al.. (2010). Increased serum S100B in never-medicated and medicated schizophrenic patients. Journal of Psychiatric Research. 44(16). 1236–1240. 38 indexed citations

Zhang, Xiang Yang, Mei Hong Xiu, Da Chun Chen, et al.. (2009). Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements. Journal of Psychiatric Research. 44(7). 429–433. 17 indexed citations

Zhang, Xiang Yang, Da Chun Chen, Ling Qi, et al.. (2009). Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia. Psychopharmacology. 205(4). 647–654. 27 indexed citations

Sun, Shilong, Fan Wang, Jun Wei, et al.. (2008). Association between interleukin-3 receptor alpha polymorphism and schizophrenia in the Chinese population. Neuroscience Letters. 440(1). 35–37. 20 indexed citations

Zhang, Xiang Yang, Lian Yuan Cao, Cai Song, et al.. (2008). Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics. Psychopharmacology. 201(3). 383–389. 33 indexed citations

Zhang, Xiangyang, Yun Tan, Dong Zhou, et al.. (2007). Nicotine Dependence, Symptoms and Oxidative Stress in Male Patients with Schizophrenia. Neuropsychopharmacology. 32(9). 2020–2024. 43 indexed citations

Yang, Li, Bao Wang, Cheng Long, Gui Ying Wu, & Hui Zheng. (2007). Increased asynchronous release and aberrant calcium channel activation in amyloid precursor protein deficient neuromuscular synapses. Neuroscience. 149(4). 768–778. 44 indexed citations

Zhang, Xiangyang, Dong Zhou, Gui Ying Wu, et al.. (2007). BDNF Levels and Genotype are Associated with Antipsychotic-Induced Weight Gain in Patients with Chronic Schizophrenia. Neuropsychopharmacology. 33(9). 2200–2205. 91 indexed citations

Zhang, Xiang Yang, Yun Tan, Dong Zhou, et al.. (2006). Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. Journal of Psychiatric Research. 41(12). 997–1004. 76 indexed citations

10.

Tan, Yun, Dong Zhou, Lian Yuan Cao, et al.. (2006). REMOVED: Association between the BDNF C270T polymorphism and negative symptoms of schizophrenia. Schizophrenia Research. 1 indexed citations

11.

Zhang, Xiang Yang, Dong Zhou, Lian Yuan Cao, & Gui Ying Wu. (2006). The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology. 188(1). 12–17. 20 indexed citations

12.

Zhang, Xiangyang, Yun Tan, Lian Yuan Cao, et al.. (2005). Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophrenia Research. 81(2-3). 291–300. 227 indexed citations

13.

Zhang, Xiang Yang, Dong Zhou, Lian Yuan Cao, Gui Ying Wu, & Yu Shen. (2005). Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics. Neuropsychopharmacology. 30(8). 1532–1538. 174 indexed citations

14.

Zhang, Xiangyang, Dong Zhou, Lian Yuan Cao, et al.. (2004). Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment With Risperidone and Haloperidol. The Journal of Clinical Psychiatry. 65(7). 940–947. 159 indexed citations

15.

Zhang, Xiangyang, Dong Zhou, Lian Yuan Cao, Pei Yan Zhang, & Gui Ying Wu. (2003). Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms. Psychiatry Research. 117(1). 85–88. 63 indexed citations

16.

Zhang, Xiang Yang, Dong Zhou, Lian Yuan Cao, Pei Yan Zhang, & Gui Ying Wu. (2002). Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+ cells in medication-free patients with schizophrenia. Journal of Psychiatric Research. 36(5). 331–336. 28 indexed citations

17.

Zhang, Xiangyang, et al.. (2002). Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia. Psychiatry Research. 109(3). 297–302. 27 indexed citations

18.

Zhang, Xiang Yang, Dong Zhou, Pei Yan Zhang, et al.. (2002). Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophrenia Research. 57(2-3). 247–258. 171 indexed citations

19.

Zhang, Xiang Yang, et al.. (2001). A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients With Schizophrenia. The Journal of Clinical Psychiatry. 62(11). 878–883. 73 indexed citations

20.

Zhou, Dong, et al.. (2001). Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study. International Clinical Psychopharmacology. 16(6). 325–330. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact